Back to company

OLANDER CLINICAL CONSULTING K/S: Financial statements 2021

CVR: 35860177

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,798,004 and a net result of DKK 1,758,667 compared with DKK 1,501,968 the year before. That is an increase of 17.1% compared with the year before. Equity amounted to DKK 687,249. The solvency ratio was 79.9%.

Gross Profit
1,798,004 kr.
Profit/Loss
1,758,667 kr.
Equity
687,249 kr.
Total Assets
860,103 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1.8 mio.1.8 mio.687 t.-
2020-1.5 mio.1.5 mio.461 t.-
2019-1.4 mio.1.4 mio.491 t.-
2018-1.7 mio.1.7 mio.700 t.-
2017-1.3 mio.1.3 mio.518 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like OLANDER CLINICAL CONSULTING K/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

OLANDER CLINICAL CONSULTING K/S: The 2020 annual report is outJul 6, 2021

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2020. Gross profit came to DKK 1,535,704, and the net result was DKK 1,501,968.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.